Billiontoone (BLLN) Competitors

$87.94 -2.65 (-2.93%)

Closing price 05/14/2026 04:00 PM Eastern

Extended Trading

$88.44 +0.50 (+0.57%)

As of 05:10 AM Eastern

BLLN vs. GH, FMS, BTSG, CELC, and HIMS

Should you buy Billiontoone stock or one of its competitors? MarketBeat compares Billiontoone with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Billiontoone include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Celcuity (CELC), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

How does Billiontoone compare to Guardant Health?

Billiontoone (NASDAQ:BLLN) and Guardant Health (NASDAQ:GH) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

Billiontoone presently has a consensus price target of $125.29, indicating a potential upside of 42.47%. Guardant Health has a consensus price target of $129.42, indicating a potential upside of 31.18%. Given Billiontoone's higher possible upside, equities research analysts clearly believe Billiontoone is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86

In the previous week, Guardant Health had 15 more articles in the media than Billiontoone. MarketBeat recorded 21 mentions for Guardant Health and 6 mentions for Billiontoone. Guardant Health's average media sentiment score of 0.56 beat Billiontoone's score of 0.34 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	7 Very Positive mention(s)	2 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Billiontoone has a net margin of 0.00% compared to Guardant Health's net margin of -40.10%.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Guardant Health	-40.10%	N/A	-26.42%

Billiontoone has higher earnings, but lower revenue than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	13.26	$7.45M	$0.55	159.89
Guardant Health	$982.02M	13.32	-$416.28M	-$3.39	N/A

Summary

Guardant Health beats Billiontoone on 8 of the 14 factors compared between the two stocks.

How does Billiontoone compare to Fresenius Medical Care AG & Co. KGaA?

Billiontoone (NASDAQ:BLLN) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

In the previous week, Billiontoone had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 6 mentions for Billiontoone and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.23 beat Billiontoone's score of 0.34 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Billiontoone. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	13.26	$7.45M	$0.55	159.89
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.31

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Billiontoone's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Billiontoone currently has a consensus price target of $125.29, indicating a potential upside of 42.47%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, indicating a potential upside of 30.27%. Given Billiontoone's stronger consensus rating and higher possible upside, equities analysts plainly believe Billiontoone is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56

Summary

Fresenius Medical Care AG & Co. KGaA beats Billiontoone on 8 of the 14 factors compared between the two stocks.

How does Billiontoone compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, BrightSpring Health Services had 3 more articles in the media than Billiontoone. MarketBeat recorded 9 mentions for BrightSpring Health Services and 6 mentions for Billiontoone. BrightSpring Health Services' average media sentiment score of 0.95 beat Billiontoone's score of 0.34 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

BrightSpring Health Services currently has a consensus price target of $56.29, indicating a potential downside of 3.62%. Billiontoone has a consensus price target of $125.29, indicating a potential upside of 42.47%. Given Billiontoone's higher probable upside, analysts clearly believe Billiontoone is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

BrightSpring Health Services has higher revenue and earnings than Billiontoone. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	0.88	$190.67M	$1.41	41.42
Billiontoone	$305.11M	13.26	$7.45M	$0.55	159.89

BrightSpring Health Services has a net margin of 2.27% compared to Billiontoone's net margin of 0.00%. BrightSpring Health Services' return on equity of 14.63% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Billiontoone	N/A	N/A	N/A

Summary

BrightSpring Health Services beats Billiontoone on 11 of the 14 factors compared between the two stocks.

How does Billiontoone compare to Celcuity?

Celcuity (NASDAQ:CELC) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

Celcuity currently has a consensus price target of $134.50, indicating a potential downside of 0.16%. Billiontoone has a consensus price target of $125.29, indicating a potential upside of 42.47%. Given Billiontoone's higher probable upside, analysts clearly believe Billiontoone is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

63.3% of Celcuity shares are owned by institutional investors. 13.3% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Billiontoone's return on equity of 0.00% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-203.17%	-52.68%
Billiontoone	N/A	N/A	N/A

Billiontoone has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.79	N/A
Billiontoone	$305.11M	13.26	$7.45M	$0.55	159.89

In the previous week, Celcuity had 4 more articles in the media than Billiontoone. MarketBeat recorded 10 mentions for Celcuity and 6 mentions for Billiontoone. Celcuity's average media sentiment score of 1.28 beat Billiontoone's score of 0.34 indicating that Celcuity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Billiontoone beats Celcuity on 7 of the 13 factors compared between the two stocks.

How does Billiontoone compare to Hims & Hers Health?

Billiontoone (NASDAQ:BLLN) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Hims & Hers Health has higher revenue and earnings than Billiontoone. Hims & Hers Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	13.26	$7.45M	$0.55	159.89
Hims & Hers Health	$2.37B	2.33	$128.37M	-$0.09	N/A

In the previous week, Hims & Hers Health had 69 more articles in the media than Billiontoone. MarketBeat recorded 75 mentions for Hims & Hers Health and 6 mentions for Billiontoone. Billiontoone's average media sentiment score of 0.34 beat Hims & Hers Health's score of 0.02 indicating that Billiontoone is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hims & Hers Health	17 Very Positive mention(s)	11 Positive mention(s)	10 Neutral mention(s)	23 Negative mention(s)	6 Very Negative mention(s)	Neutral

Billiontoone presently has a consensus price target of $125.29, suggesting a potential upside of 42.47%. Hims & Hers Health has a consensus price target of $29.50, suggesting a potential upside of 21.73%. Given Billiontoone's stronger consensus rating and higher probable upside, equities analysts plainly believe Billiontoone is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

Billiontoone has a net margin of 0.00% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Hims & Hers Health	-0.56%	6.10%	1.52%

Summary

Billiontoone beats Hims & Hers Health on 8 of the 15 factors compared between the two stocks.

Get Billiontoone News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BLLN vs. The Competition

Export

Metric	Billiontoone	Services – Health Industry	Services Sector	NASDAQ Exchange
Market Cap	$4.17B	$1.44B	$976.93M	$12.37B
Dividend Yield	N/A	N/A	4.89%	5.35%
P/E Ratio	159.89	13.42	10.72	25.63
Price / Sales	13.26	4.87	27.57	76.59
Price / Cash	279.88	3,288.92	441.45	56.33
Price / Book	8.00	4.67	3.34	6.97
Net Income	$7.45M	-$26.94M	-$2.50M	$333.62M
7 Day Performance	-5.40%	-5.57%	-2.85%	1.09%
1 Month Performance	9.09%	-5.14%	1.93%	3.08%
1 Year Performance	N/A	N/A	34.19%	35.68%

Billiontoone Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BLLN Billiontoone	3.9962 of 5 stars	$87.94 -2.9%	$125.29 +42.5%	N/A	$4.17B	$305.11M	159.89	620	Analyst Forecast
GH Guardant Health	3.3405 of 5 stars	$95.70 +3.7%	$129.16 +35.0%	+142.3%	$12.23B	$982.02M	N/A	2,506	Analyst Forecast Insider Trade
FMS Fresenius Medical Care AG & Co. KGaA	4.876 of 5 stars	$22.02 +1.7%	$28.00 +27.2%	-22.8%	$12.09B	$22.20B	11.59	1,488	Gap Down
BTSG BrightSpring Health Services	3.5395 of 5 stars	$54.83 +3.6%	$56.29 +2.7%	+148.6%	$10.27B	$12.91B	38.89	23,500
CELC Celcuity	1.7659 of 5 stars	$131.06 +0.3%	$134.50 +2.6%	+1,140.5%	$6.32B	N/A	N/A	40	News Coverage Positive News Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BLLN) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Billiontoone (BLLN) Competitors

BLLN vs. GH, FMS, BTSG, CELC, and HIMS

How does Billiontoone compare to Guardant Health?

Summary

How does Billiontoone compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Billiontoone compare to BrightSpring Health Services?

Summary

How does Billiontoone compare to Celcuity?

Summary

How does Billiontoone compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLLN vs. The Competition

Billiontoone Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Billiontoone (BLLN) Competitors

BLLN vs. GH, FMS, BTSG, CELC, and HIMS

How does Billiontoone compare to Guardant Health?

Do analysts prefer BLLN or GH?

Does the media prefer BLLN or GH?

Do insiders & institutionals believe in BLLN or GH?

Is BLLN or GH more profitable?

Which has stronger earnings & valuation, BLLN or GH?

Summary

How does Billiontoone compare to Fresenius Medical Care AG & Co. KGaA?

Does the media refer more to BLLN or FMS?

Which has preferable earnings & valuation, BLLN or FMS?

Is BLLN or FMS more profitable?

Do insiders and institutionals have more ownership in BLLN or FMS?

Do analysts recommend BLLN or FMS?

Summary

How does Billiontoone compare to BrightSpring Health Services?

Does the media prefer BTSG or BLLN?

Do analysts recommend BTSG or BLLN?

Which has better valuation and earnings, BTSG or BLLN?

Is BTSG or BLLN more profitable?

Summary

How does Billiontoone compare to Celcuity?

Do analysts recommend CELC or BLLN?

Do insiders and institutionals have more ownership in CELC or BLLN?

Is CELC or BLLN more profitable?

Which has better valuation and earnings, CELC or BLLN?

Does the media refer more to CELC or BLLN?

Summary

How does Billiontoone compare to Hims & Hers Health?

Do institutionals and insiders have more ownership in BLLN or HIMS?

Which has stronger valuation and earnings, BLLN or HIMS?

Does the media favor BLLN or HIMS?

Do analysts rate BLLN or HIMS?

Is BLLN or HIMS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLLN vs. The Competition

Billiontoone Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools